SINGAPORE (Feb 2): OCBC is reiterating its “buy” recommendation on Mapletree Greater China Commercial Trust with lower $1.03 fair value after reporting a solid set of 3Q results which came in within expectations.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply